ImmunoPrecise Antibodies Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Public

  • Employees
  • 102

Employees

  • Stock Symbol
  • IPA

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $1.26
  • (As of Friday Closing)

ImmunoPrecise Antibodies General Information

Description

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Corporate Office
  • 4837 Amber Valley Parkway
  • Suite 11
  • Fargo, ND 58104
  • United States
+1 (701) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunoPrecise Antibodies Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.26 $1.24 $0.94 - $4.22 $33.9M 26.3M 591K -$0.48

ImmunoPrecise Antibodies Financials Summary

In Thousands,
USD
TTM 31-Oct-2023 FY 2023 30-Apr-2023 FY 2022 30-Apr-2022 FY 2021 30-Apr-2021
EV 60,034 61,209 110,542 179,074
Revenue 16,766 15,522 15,427 13,667
EBITDA (8,114) (16,005) (9,778) (1,298)
Net Income (11,870) (19,950) (13,312) (5,600)
Total Assets 54,672 56,972 72,364 54,539
Total Debt 6,923 5,321 2,138 2,816
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ImmunoPrecise Antibodies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ImmunoPrecise Antibodies‘s full profile, request access.

Request a free trial

ImmunoPrecise Antibodies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The c
Biotechnology
Fargo, ND
102 As of 2023
000.00
00000000 000.00

000000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000000000
Redwood City, CA
000 As of 0000
00000
000000000 00000

000000

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut eni
0000 000000000
Abingdon, United Kingdom
000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImmunoPrecise Antibodies Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Coherus Biosciences Formerly VC-backed Redwood City, CA 000 00000 000000000 00000
Immunocore Formerly VC-backed Abingdon, United Kingdom 000 00.000 000000000 00.000
GenScript Formerly VC-backed Piscataway, NJ 0000 00000 000000000 00000
Teva Pharmaceutical Industries Corporation Petah Tikva, Israel 00000 000.00 000000000 00 000.00
MediGene Formerly VC-backed Planegg, Germany 00 00000 000000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

ImmunoPrecise Antibodies Executive Team (14)

Name Title Board Seat Contact Info
Jennifer Bath Ph.D Chief Executive Officer, President & Board Member
Brad McConn Chief Financial Officer
Kristin Taylor Chief Financial Officer
Ilse Roodink Ph.D Chief Scientific Officer
Timothy Miller Director, Business Development
You’re viewing 5 of 14 executive team members. Get the full list »

ImmunoPrecise Antibodies Board Members (8)

Name Representing Role Since
00000 000 00 Self Chairman & Board Member 000 0000
00000000 0000 00.0 ImmunoPrecise Antibodies Chief Executive Officer, President & Board Member 000 0000
00000000 000000 ImmunoPrecise Antibodies Chairman & Board Member 000 0000
You’re viewing 3 of 8 board members. Get the full list »

ImmunoPrecise Antibodies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImmunoPrecise Antibodies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ImmunoPrecise Antibodies‘s full profile, request access.

Request a free trial

ImmunoPrecise Antibodies Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Carterra (LSA Instrument Platform) 20-Mar-2024 000000000 Buildings and Property 00000000
BioStrand (Other Healthcare Technology Systems) 14-Apr-2022 0000000000 0000 Other Healthcare Technology Systems 00000000
ModiQuest Research 06-Apr-2018 0000000000 00.000 Discovery Tools (Healthcare) 00000 000
CrossBeta Biosciences 30-Jan-2018 0000000000 000.00 Biotechnology 00000 000
SERPINx 29-Dec-2017 Corporate 00000 Discovery Tools (Healthcare) 00000 000
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

ImmunoPrecise Antibodies Subsidiaries (3)

Company Name Industry Location Founded
BioStrand (Other Healthcare Technology Systems) Other Healthcare Technology Systems Diepenbeek, Belgium 2019
QVQ Holdings Biotechnology Utrecht, Netherlands 0000
CrossBeta Biosciences Biotechnology Utrecht, Netherlands 0000
To view ImmunoPrecise Antibodies’s complete subsidiaries history, request access »

ImmunoPrecise Antibodies Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
SERPINx 29-Dec-2017 000000000 00000 Completed
  • 0000000000000 0000
To view ImmunoPrecise Antibodies’s complete exits history, request access »

ImmunoPrecise Antibodies FAQs

  • When was ImmunoPrecise Antibodies founded?

    ImmunoPrecise Antibodies was founded in 1983.

  • Who is the CEO of ImmunoPrecise Antibodies?

    Jennifer Bath Ph.D is the CEO of ImmunoPrecise Antibodies.

  • Where is ImmunoPrecise Antibodies headquartered?

    ImmunoPrecise Antibodies is headquartered in Fargo, ND.

  • What is the size of ImmunoPrecise Antibodies?

    ImmunoPrecise Antibodies has 102 total employees.

  • What industry is ImmunoPrecise Antibodies in?

    ImmunoPrecise Antibodies’s primary industry is Biotechnology.

  • Is ImmunoPrecise Antibodies a private or public company?

    ImmunoPrecise Antibodies is a Public company.

  • What is ImmunoPrecise Antibodies’s stock symbol?

    The ticker symbol for ImmunoPrecise Antibodies is IPA.

  • What is the current stock price of ImmunoPrecise Antibodies?

    As of 19-Apr-2024 the stock price of ImmunoPrecise Antibodies is $1.26.

  • What is the current market cap of ImmunoPrecise Antibodies?

    The current market capitalization of ImmunoPrecise Antibodies is $33.9M.

  • What is ImmunoPrecise Antibodies’s current revenue?

    The trailing twelve month revenue for ImmunoPrecise Antibodies is $16.8M.

  • Who are ImmunoPrecise Antibodies’s competitors?

    Coherus Biosciences, Immunocore, GenScript, Teva Pharmaceutical Industries, and MediGene are some of the 7 competitors of ImmunoPrecise Antibodies.

  • What is ImmunoPrecise Antibodies’s annual earnings per share (EPS)?

    ImmunoPrecise Antibodies’s EPS for 12 months was -$0.48.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »